Paraplegic can now walk after stem cell treatment

  MILLERTON, OKLAHOMA - 01/14/2017 (PRESS RELEASE JET)

Hospitals and orthopedic surgeons can now evaluate a new treatment for spinal cord injury.  Research results have demonstrated the world's first success in treating a spinal cord injury with only a topical rub-on ointment that penetrates deeply and converts normal cells into stem cells.  Until recently, this kind of simple rub-it-on treatment has never before been used to transform a paraplegic into a walking, functioning person. 

The treatment relies on a new formulation that creates stem cells deep below the skin using only a highly-penetrating ointment.  The FDA-registered ointment is called TetraStem.  TetraStem is an antibiotic normally used to treat cuts, as an on-label topical drug.  But it was discovered 5 years ago that it also can induce stem-cell healing; first in an animal research program and then in human research programs.  The new ointment is being developed by the world's only not-for-profit FDA-registered drug manufacturing company.

Miranda is the first patient to benefit from this simple but effective experimental treatment.  Miranda's treatment and progress is reported online at www.PhillipsCompany.4T.com/Miranda.pdf

TetraStem is being developed by Phillips Company, who now offers any hospital or orthopedic surgeon the opportunity to evaluate this new drug in the treatment of spinal cord injury.